These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 5658439)

  • 1. Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses.
    Chirigos MA; Perk K; Turner W; Burka B; Gomez M
    Cancer Res; 1968 Jun; 28(6):1055-63. PubMed ID: 5658439
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus.
    Turner W; Chirigos MA
    Cancer Res; 1969 Nov; 29(11):1956-60. PubMed ID: 5358213
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on the biological relationship of murine leukemia viruses and on kidney lesions of mice with leukemia induced by these viruses.
    Recher L; Tanaka T; Sykes JA; Yumoto T; Seman G; Young L; Dmochowski L
    Natl Cancer Inst Monogr; 1966 Sep; 22():459-79. PubMed ID: 4288567
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA; Chirigos MA; Chan SP
    Cancer Res; 1969 May; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice.
    Fefer A; McCoy JL; Perk K; Glynn JP
    Cancer Res; 1968 Aug; 28(8):1577-85. PubMed ID: 4876979
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of a rhabdomyosarcoma (undifferentiated type) in rats induced by a murine sarcoma virus (Moloney).
    Perk K; Shachat DA; Moloney JB
    Cancer Res; 1968 Jun; 28(6):1197-206. PubMed ID: 5658448
    [No Abstract]   [Full Text] [Related]  

  • 7. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. II. Morphologic studies.
    Stanton MF; Law LW; Ting RC
    J Natl Cancer Inst; 1968 May; 40(5):1113-29. PubMed ID: 5689654
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of viral oncogenicity by the prior administration of dimethyl sulfoxide.
    Warren J; Sacksteder MR; Ellis BM; Schwartz RD
    Cancer Res; 1973 Mar; 33(3):618-22. PubMed ID: 4347720
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleoside deaminase activity in viral leukemia.
    Rothman IK; Malathi VG; Silber R
    Cancer Res; 1971 Mar; 31(3):274-6. PubMed ID: 5547216
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the neutralization of the oncogenicity of Friend, Moloney, and Rauscher viruses.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1968 May; 28(5):942-6. PubMed ID: 4870883
    [No Abstract]   [Full Text] [Related]  

  • 11. The age related responses of New Zealand mice to a murine sarcoma virus.
    Gazdar AF; Beitzel W; Talal N
    Clin Exp Immunol; 1971 Mar; 8(3):501-9. PubMed ID: 5576664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative dose-response relationships of murine sarcoma virus (Moloney) in BALB/c mice.
    Blumenschein GR; Moloney JB
    J Natl Cancer Inst; 1969 Jan; 42(1):123-33. PubMed ID: 5765223
    [No Abstract]   [Full Text] [Related]  

  • 13. An anemia-inducing virus derived from tumors caused by murine sarcoma virus--Moloney.
    Taylor DO; Cremer NE; Oshiro LS; Lennette EH
    J Natl Cancer Inst; 1972 Sep; 49(3):829-45. PubMed ID: 4345969
    [No Abstract]   [Full Text] [Related]  

  • 14. Concentration by Diaflo ultrafiltration of murine leukemia and sarcoma viruses grown in tissue cultures.
    Rhim JS; Williams LB; Huebner RJ; Turner HC
    Cancer Res; 1969 Jan; 29(1):154-6. PubMed ID: 4303443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Factors regulating the spontaneous regression of primary tumors induced by murine sarcoma virus, Moloney strain, in mice (BALB-c-Cb-Se). I. Age at treatment and virus doses].
    Ribacchi R; Giraldo G
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1967; 27(3):167-76. PubMed ID: 5605880
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of antisera to interferon in studying oncogenic viruses.
    Inglot AD; Oleszak E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):529-36. PubMed ID: 219809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and regression of primary moloney sarcoma virus-induced tumors in mice.
    Fefer A; McCoy JL; Glynn JP
    Cancer Res; 1967 Sep; 27(9):1626-31. PubMed ID: 4860892
    [No Abstract]   [Full Text] [Related]  

  • 18. [The stimulating influence of histone on the oncogenicity of Moloney mouse sarcoma virus in vivo].
    Tatarinova IuN; Kol'tsov VD; Lushnikov AA; Krymskaia LL; Amchenkova AM
    Vopr Virusol; 1972; 17(4):486-90. PubMed ID: 5086861
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nature of the target cells for Rauscher and Friend leukemia viruses].
    Sanin AV; Khorobrykh VV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (8):5-20. PubMed ID: 6996749
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological and pathological manifestations of murine sarcoma virus (Moloney) infections.
    Schlom J; Moloney JB; Groupé V
    Cancer Res; 1970 Dec; 30(12):2955-61. PubMed ID: 5494580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.